左卡尼汀对维持性血液透析患者营养指标及炎症状态的影响.pdf

华西医学 2016, 31（1） West China Medical Journal, , Jan. 2016 25
group were injected with levocarnitine ( g
once) after every dialysis for 3 months, while patients in the control group only accepted routine hemodialysis therapy. Blood
biochemical indicators, serum high sensitive C-reactive protein (hs-CRP) were measured and compared at the experiment
onset and 3 months later. Results  After treatment with levocarnitine for three months, the average serum levels of albumin
(Alb), hemoglobin (Hb), triacylglycerol (TG), high density lipoprotein cholesterol (HDL-C) and hs-CRP, and the conditions
of dialysis hypotension, muscular spasm, lacking in strength, and anorexia were significantly different between the two groups
(P ＜ ). But there was no significant difference in total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C)
between the two groups (P ＞ ). For the control group, after treatment, Alb, Hb and condition of anorexia changed
significantly (P ＜ ), while TC, TG, LDL-C, HDL-C, hs-CRP, conditions of dialysis hypotension, muscular spasm and
lacking of strength did not change (P ＞ ); for the treatment group, after treatment, all Alb, Hb, TG, HDL-C, hs-CRP,
conditions of dialysis hypotension, muscular spasm, lacking of strength and anorexia changed significantly (P ＜ 0.